Cargando…
Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs
Ginkgolide B (GB), an important active constituent of Ginkgo biloba extract, has been used in clinical applications for the treatment of dementia, cerebral insufficiency or related cognitive decline. To investigate the main pharmacokinetic characteristics of three different GB formulations in beagle...
Autores principales: | Zhao, Jie, Geng, Ting, Wang, Qi, Si, Haihong, Sun, Xiaoping, Guo, Qingming, Li, Yanjing, Huang, Wenzhe, Ding, Gang, Xiao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332382/ https://www.ncbi.nlm.nih.gov/pubmed/26561795 http://dx.doi.org/10.3390/molecules201119678 |
Ejemplares similares
-
Correction: Zhao, J., et al. Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs. Molecules 2015, 20, 20031–20041
por: Zhao, Jie, et al.
Publicado: (2016) -
Transformation of multi-component ginkgolide into ginkgolide B by Coprinus comatus
por: Ding, HongXue, et al.
Publicado: (2015) -
Optimizing the Formulation for Ginkgolide B Solid Dispersion
por: Wu, Xiao, et al.
Publicado: (2018) -
Comparing the role of Ginkgolide B and Ginkgolide K on cultured astrocytes exposed to oxygen-glucose deprivation
por: Yu, Wen-Bo, et al.
Publicado: (2018) -
Biosynthesis pathways of ginkgolides
por: Zeng, Zihan, et al.
Publicado: (2013)